Alphatec COO Scott Lish Sells Nearly 20,000 Shares for Approximately $390,836
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: Fool
- Insider Transaction Overview: Alphatec COO Scott Lish executed an open-market sale of 19,900 shares on December 16, 2025, for approximately $390,836, indicating his ongoing engagement with the company's stock despite a reduction in his holdings to 641,432 shares, valued at around $12.67 million post-sale.
- Transaction Size Analysis: The sale of 19,900 shares closely aligns with Lish's historical median trade size, slightly exceeding the recent median for sell-only trades, reflecting a consistent selling cadence that indicates a structured liquidity strategy amid strong market conditions.
- Market Environment Impact: With Alphatec shares delivering a total return of 108.7% over the past year, Lish's sale occurred during a period of stock appreciation, showcasing his awareness of market dynamics, even as the company continues to operate at a loss but has reduced its operating deficit.
- Investor Confidence: Despite selling nearly 20,000 shares, Lish retains over 640,000 shares, signaling his confidence in the company's future; investors should monitor stock price fluctuations to identify optimal buying opportunities.
ATEC
$20.965+Infinity%1D
Analyst Views on ATEC
Wall Street analysts forecast ATEC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATEC is 23.00 USD with a low forecast of 16.00 USD and a high forecast of 27.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Analyst Rating
10 Buy
1 Hold
0 Sell
Strong Buy
Current: 20.770
Low
16.00
Averages
23.00
High
27.00
Current: 20.770
Low
16.00
Averages
23.00
High
27.00
About ATEC
Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. The Company's Organic Innovation Machine is focused on developing new approaches that integrate with its expanding Alpha InformatiX (AIX) Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include AIX, positioners, access systems, implants and fixation systems, and biologics. Its AIX product platform comprises its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and its navigation-enabled robotics platform (Valence). It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
